Author(s):
Pawan. N. Karwa, Ramesh D Ingole, Avinash. B Thalkari
Email(s):
karwapawan99@gmail.com
DOI:
10.52711/2349-2988.2021.00026 
Address:
Mr. Pawan. N. Karwa1, Dr. Ramesh D Ingole2, Mr. Avinash. B Thalkari3
1Gurukrupa Institute of Pharmacy, [Degree] Malipargaon Phata Majalgaon, Dist. Beed, Maharashtra, 431131.
2DJPS College of Pharmacy, Pathari.
3Vasant Pharmacy College, Kaij.
*Corresponding Author
Published In:
Volume - 13,
Issue - 3,
Year - 2021
ABSTRACT:
Deep vein thrombosis commonly known as DVT has globally about 1–2 per 1000 population cases. The rate of Mortality is high; About 6% death cases occurs within primary 30 days of DVT by the primarily through pulmonary embolism, and also about 13% of patients with the pulmonary embolism. Among treated patients, about 20–50% develop post-thrombotic syndrome (PTS) after DVT, and 3% develop chronic thromboembolic pulmonary hypertension after pulmonary embolism.3,4 After 3–6 months of anticoagulation, VTE recurs in up to 40% of patients within 10 years. The risk of recurrence is two- to threefold higher after unprovoked than provoked VTE. Deep Vein thrombosis (DVT) is a life-threatening condition which may lead to sudden death as an immediate complication due to formation of thrombo-embolism. DVT is associated with various risk factors such as prolonged immobilization, inflammation, and/or coagulation disorders including muscular or venous injury. Deep venous thrombosis (DVT) frequently occurs in the lower limb. Successful treatment of DVT exclusively by the use of the different remedies has rarely been recorded in peer-reviewed journals. The present case report intends to record yet another case of DVT in a patient cured exclusively Since this report is based on a single case of recovery, results of more such cases are warranted to strengthen the outcome of the present study.
Cite this article:
Pawan. N. Karwa, Ramesh D Ingole, Avinash. B Thalkari. Case study on Deep Vein Thrombosis with its Systemic management. Research Journal of Science and Technology. 2021; 13(3):170-2. doi: 10.52711/2349-2988.2021.00026
Cite(Electronic):
Pawan. N. Karwa, Ramesh D Ingole, Avinash. B Thalkari. Case study on Deep Vein Thrombosis with its Systemic management. Research Journal of Science and Technology. 2021; 13(3):170-2. doi: 10.52711/2349-2988.2021.00026 Available on: https://rjstonline.com/AbstractView.aspx?PID=2021-13-3-2
REFERENCES:
1. Kaur R, Chhabra S, Singh A (2015) Role of Ayurvedic medicine and leech therapy in management of deep vein thrombosis: A case study. J Biol Sci Opin 3(2): 87-90.
2. Scarvelis D, Wells PS (2006) Diagnosis and treatment of deep-vein thrombosis. CMAJ 175(9): 1087-1092.
3. Saxena V, Shukla D, Bharadwaj PK (2012) Evaluation of effect of Jalukavacharana on deep vein thrombosis. The Indian Journal of Research 6: 42-45.
4. Kesieme E, Kesieme C, Jebbin N, Irekpita E, Dongo A (2011) Deep vein thrombosis: A clinical review. J Blood Med 2: 59-69.
5. Narani KK (2010) Deep vein thrombosis and pulmonary embolism- prevention, management and anaesthetic consideration. Indian J Anaesth 54(1): 8-17.
6. Robert-Ebadi H, Righini M. Management of distal deep vein thrombosis. Thromb Res 2017 Jan;149:48e55. https://doi.org/10.1016/ J. Thromres.2016.11.009. Epub 2016 Nov 10.
7. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004;350:2558e63.
8. Rosendaal FR. Causes of venous thrombosis. Thromb J 2016;14(Suppl 1):24.
9. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: pro- spective cohort study. Lancet 2003; 362:523e6.
10. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population- based study. J Thromb Haemost 2007; 5:692e9.
11. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost 2014;12(10): 1580e90.
12. Deitelzweig SB, Johnson BH, Lin J, Schulman KL. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am JHematol 2011;86(2):217e20 [Cross Reference View Record in Scopus].
13. Lee AD, Stephen E, Agarwal S, Premkumar P. Venous thromboembolism in India. Eur J Vasc Endovasc Surg 2009;37:482e5.
14. Vandenbroucke JP, Rosing J, Bloemenkamp KW, Middeldrop S, Helmerhorst FM, Bouma BN, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001; 344:1527e35.
15. Wadhwani GG. A case of deep vein thrombosis with post thrombotic syndrome cured by homoeopathic therapy. Indian J Res Homoeopath 2015;9(4): 267e73.